ENHO and gestational diabetes: For both maternal (2.4 ± 2.0 ng/mL) and cord blood (1.5 ± 0.9 ng/mL), significantly lower adropin levels were observed in the GDM cohort in comparison to the non-diabetic control group (3.3 ± 1.3 ng/mL and 3.3 ± 1.3 ng/mL, respectively).